
Kenai Therapeutics
Operator of a biotechnology company intended to cure neurological disease. The company offers off-the-shelf neuron replacement therapies as potent disease-modifying treatments for neurological disorde...
Valuation
$110M
Latest known
Share Price
N/A
Total Raised
$86.8M
Last Round
N/A